21 April 2020 in Radiology
Wide variation in prostate cancer detection is seen across all Prostate Imaging Reporting and Data System scores for men with suspected or biopsy-proven untreated prostate cancer who undergo MRI. Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) helps provide a stand...
1 December 2010 in Radiology
Our study suggests that the combination of diffusion-weighted and dynamic contrast-enhanced MR imaging has the potential to improve the differentiation of prostate cancer from benign prostatic hype... PurposeTo analyze the diffusion and perfusion parameters of central gland (CG) prostate cancer, stromal hyperplasia (SH), and glandular hyperplasia (GH) and to determine the role of these parameter...
1 December 2011 in American Journal of Roentgenology
OBJECTIVE. The objective of our study was to investigate whether quantitative parameters derived from diffusion-weighted imaging (DWI) and dynamic contrast-enhanced MRI (DCE-MRI) correlate with Gleason score and angiogenesis of prostate cancer. MATERIALS AND METHODS. Seventy-three patients who underwent preoperative MRI and radical prostatectomy were included in our study. A radiologist and pathologist located the dominant tumor on the MR images based on histopathologic correlation. For each dominant tumor, the apparent diffusion coefficient (ADC) value and quantitative DCE-MRI parameters (i.e., contrast agent transfer rate between blood and tissue [Ktrans], extravascular extracellular fractional volume [ve], contrast agent backflux rate constant [kep], and blood plasma fractional volume on a voxel-by-voxel basis [vp]) were calculated and the Gleason score was recorded. The mean blood vessel count, mean vessel area fraction, and vascular endothelial growth factor (VEGF) expression of the dominant tumor we...
1 May 2009 in Academic Radiology
24 February 2011 in Journal of Magnetic Resonance Imaging
Purpose: To determine relative diagnostic value of MR diffusion and perfusion parameters in detection of active small bowel inflammation in patients with Crohn's disease (CD).Materials and Methods: We reviewed 18 patients with active CD of terminal ileum (TI) who underwent MR enterography (MRE; including dynamic contrast enhanced MRI and diffusion‐weighted MRI). Conventional MRI findings of TI were recorded. Regions of interest were drawn over TI and normal ileum to calculate apparent diffusion coefficient (ADC), the volume transfer constant (Ktrans) and the contrast media distribution volume (ve). Receiver operating characteristic analysis was used to determine their diagnostic performance.Results: Among conventional MR findings, mural thickening and increased enhancement were present in all actively inflamed small bowel. Ktrans, ve, and ADC values differed significantly between actively inflamed TI and normal ileum (0.92 s−1 versus 0.36 s−1; 0.31 versus 0.15 ± 0.08; 0.00198 mm2/s versus 0.00311 mm2/s; P < 0.001). Area under the curve (AUC) for Ktrans, ve, and ADC values ranged from 0.88 to 0.92 for detection of active inflammation. Combining Ktrans and ADC data provided an AUC value of 0.95.Conclusion: Dynamic contrast‐enhanced MRI (DCE‐MRI) and diffusion‐weighted imaging (DWI) provide quantitative measures of small bowel inflammation that can differentiate actively inflamed small bowel segments from normal small bowel in CD. DWI provides better sensitivity compared with DCE‐MRI and combination of ADC and Ktrans parameters for analysis can potentially improve specificity. J. Magn. Reson. Imaging 2011;.